Abstract
Gonadotropin-releasing hormone (GnRH) agonists are commonly used for hormonal treatment of advanced prostate cancer. Pituitary apoplexy is a very rare, but life-threatening reaction to this treatment. Onset of symptoms could start as early as an hour after injection. We encountered a patient with known pituitary macroadenoma who developed pituitary apoplexy shortly after leuprolide administration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
